GL Pharm Tech Dividends and Buybacks
Dividend criteria checks 0/6
GL Pharm Tech does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-11.8%
Buyback Yield
| Total Shareholder Yield | -11.8% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Is GL Pharm Tech (KOSDAQ:204840) A Risky Investment?
Jul 23
Market Participants Recognise GL Pharm Tech Corp.'s (KOSDAQ:204840) Revenues Pushing Shares 25% Higher
Mar 01Would GL Pharm Tech (KOSDAQ:204840) Be Better Off With Less Debt?
Mar 30The GL Pharm Tech (KOSDAQ:204840) Share Price Is Up 50% And Shareholders Are Holding On
Dec 15Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if A204840's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if A204840's dividend payments have been increasing.
Dividend Yield vs Market
| GL Pharm Tech Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A204840) | n/a |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 4.0% |
| Industry Average (Pharmaceuticals) | 1.1% |
| Analyst forecast (A204840) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate A204840's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate A204840's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate A204840's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as A204840 has not reported any payouts.